Abstract P1128: Trajectories of Physical Activity Before and After Cardiovascular Disease Events in a Diverse Cohort
Abstract
Background: Physical activity plays a critical role in cardiovascular health throughout the life course. However, data on its trajectories before and after cardiovascular disease (CVD) are limited. We analyzed a bi-racial U.S. cohort with 35 years of repeated assessments of moderate-to-vigorous-intensity physical activity (MVPA) to examine trends and potential variations by race. Methods: CARDIA participants (n=5,115) underwent up to 10 MVPA assessments from 1985-6 to 2020-2. MVPA was assessed via a Physical Activity History Questionnaire and scored in exercise units (EU), with 300 EU approximating 150 minutes/week. During follow-up, 332 participants experienced an incident non-fatal CVD event, and 236 (71%) had subsequent MVPA data, forming the case group. Nested controls were matched 1:1 to cases by age, sex, and race using risk set sampling. LOESS regression explored non-linear MVPA trends, while linear mixed-effects models assessed differences in MVPA slopes between groups. Generalized estimating equation (GEE) models evaluated the odds ratio (OR) of low MVPA (<300 EU) post-CVD. Results: The mean baseline age of the matched sample (n=472) was 26 years; 64% were Black, and 60% were men. The mean age at incident CVD was 49 years. The median (IQR) number of MVPA assessments in cases was 6 (5-8) before and 2 (1-3) after CVD. MVPA levels were consistently higher in controls than in cases, with the gap widening after CVD (Figure), supported by a significant time-by-CVD status interaction ( P = .002). The OR for low MVPA post-CVD in cases vs. controls was 2.45 (95% CI: 1.76-3.41) and was stronger in Black (OR = 3.67, 95% CI: 2.36-5.70) than in White (OR = 1.49, 95% CI: 0.90-2.48) participants ( P interaction = .017). No heterogeneity was detected across CVD types (CHD, stroke, heart failure; P = .90). Conclusions: MVPA levels were consistently lower in cases than controls, with a more pronounced decrease after CVD, perhaps due to physical limitations. The odds of lower-than-recommended MVPA post-CVD were notably higher among Black participants.
Article Details
Authors (9)
Yariv Gerber
Tel Aviv University, Rockville, Maryland, United States
Kelley Gabriel
University of Alabama at Birmingham, Birmingham, Alabama, United States
David Jacobs
University of Minnesota, Minnetonka, Minnesota, United States
Jared Reis
NATIONAL HEART LUNG BLOOD INST, Bethesda, Maryland, United States
Joe Shearer
National Institutes of Health, Bethesda, Maryland, United States
Cora Lewis
Univeristy of Alabama at Birmingham, Birmingham, Alabama, United States
Mercedes Carnethon
NORTHWESTERN UNIVERSITY, Chicago, Illinois, United States
Stephen Sidney
Kaiser Permanente, Oakland, California, United States
Veronique Roger